Literature DB >> 16152649

Molecular study of WISP3 in nine families originating from the Middle-East and presenting with progressive pseudorheumatoid dysplasia: identification of two novel mutations, and description of a founder effect.

Valérie Delague1, Eliane Chouery, Sandra Corbani, Ismat Ghanem, Suhail Aamar, Judith Fischer, Ephrat Levy-Lahad, J Andoni Urtizberea, André Mégarbané.   

Abstract

Progressive pseudorheumatoid dysplasia (PPD) is a rare autosomal recessive syndrome characterized by the presence of spondyloepiphyseal dysplasia associated with pain, stiffness, and swelling of multiple joints, osteoporosis, and the absence of destructive bone changes. The disorder is caused by mutations of the WISP3 gene located on chromosome 6q22. We hereby report the molecular study of the WISP3 gene in nine unrelated consanguineous families originating from the Middle-East: three from Lebanon, five from Syria, and one from Palestinian Bedouin descent, all affected with PPD. Five different sequence variations were identified in the WISP3 gene, two of them being new mutations: the c.589G --> C transversion at codon 197, responsible for a splicing defect (A197fsX201); and the c.536_537delGT deletion (C179fsX), both in exon 3. In all other families, the affected patients were homozygous for a previously described nonsense mutation, namely c.156C --> A (C52X). Interestingly, in the latter families, the C52X mutation was always found associated with a novel c.248G --> A (G83E) variation, suggesting the existence of a founder effect. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16152649     DOI: 10.1002/ajmg.a.30906

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  20 in total

1.  Novel COL2A1 variant (c.619G>A, p.Gly207Arg) manifesting as a phenotype similar to progressive pseudorheumatoid dysplasia and spondyloepiphyseal dysplasia, Stanescu type.

Authors:  Julie Jurgens; Nara Sobreira; Peggy Modaff; Catherine A Reiser; Soo Hyun Seo; Moon-Woo Seong; Sung Sup Park; Ok Hwa Kim; Tae-Joon Cho; Richard M Pauli
Journal:  Hum Mutat       Date:  2015-08-06       Impact factor: 4.878

Review 2.  Progressive pseudorheumatoid dysplasia: a report of three cases and a review of radiographic and magnetic resonance imaging findings.

Authors:  Christy B Pomeranz; Janet R Reid
Journal:  Skeletal Radiol       Date:  2019-02-02       Impact factor: 2.199

Review 3.  Progressive pseudorheumatoid dysplasia: a rare childhood disease.

Authors:  Sofia Torreggiani; Marta Torcoletti; Belinda Campos-Xavier; Francesco Baldo; Carlo Agostoni; Andrea Superti-Furga; Giovanni Filocamo
Journal:  Rheumatol Int       Date:  2018-10-16       Impact factor: 2.631

4.  The CCN family member Wisp3, mutant in progressive pseudorheumatoid dysplasia, modulates BMP and Wnt signaling.

Authors:  Yukio Nakamura; Gilbert Weidinger; Jennifer O Liang; Allisan Aquilina-Beck; Keiko Tamai; Randall T Moon; Matthew L Warman
Journal:  J Clin Invest       Date:  2007-10       Impact factor: 14.808

5.  Novel and recurrent mutations of WISP3 in two Chinese families with progressive pseudorheumatoid dysplasia.

Authors:  Jing Sun; Weibo Xia; Shuli He; Zhen Zhao; Min Nie; Mei Li; Yan Jiang; Xiaoping Xing; Ou Wang; Xunwu Meng; Xueying Zhou
Journal:  PLoS One       Date:  2012-06-07       Impact factor: 3.240

6.  Clinical and molecular characterization of a patient with interstitial 6q21q22.1 deletion.

Authors:  Elisa Tassano; Marisol Mirabelli-Badenier; Edvige Veneselli; Aldamaria Puliti; Margherita Lerone; Carlotta Maria Vaccari; Giovanni Morana; Simona Porta; Giorgio Gimelli; Cristina Cuoco
Journal:  Mol Cytogenet       Date:  2015-04-28       Impact factor: 2.009

7.  A homozygous deletion of exon 1 in WISP3 causes progressive pseudorheumatoid dysplasia in two siblings.

Authors:  Barbara Neerinckx; Cedric Thues; Carine Wouters; Sarah Lechner; Rene Westhovens; Hilde Van Esch
Journal:  Hum Genome Var       Date:  2015-12-03

8.  Skeletal phenotype/genotype in progressive pseudorheumatoid chondrodysplasia.

Authors:  Ali Al Kaissi; Vladimir Kenis; Lamia Ben Jemaa; Hela Sassi; Mohammad Shboul; Franz Grill; Rudolf Ganger; Susanne Gerit Kircher
Journal:  Clin Rheumatol       Date:  2019-10-18       Impact factor: 2.980

9.  The combined prevalence of classified rare rheumatic diseases is almost double that of ankylosing spondylitis.

Authors:  Judith Leyens; Tim Th A Bender; Martin Mücke; Christiane Stieber; Dmitrij Kravchenko; Christian Dernbach; Matthias F Seidel
Journal:  Orphanet J Rare Dis       Date:  2021-07-22       Impact factor: 4.123

10.  A Wisp3 Cre-knockin allele produces efficient recombination in spermatocytes during early prophase of meiosis I.

Authors:  Steven Hann; Laura Kvenvold; Brittney N Newby; Minh Hong; Matthew L Warman
Journal:  PLoS One       Date:  2013-09-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.